Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5535)
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
8,159
Price
$39.22
Total Value
$319.96K
Shares Held After
293,059
% of Holdings
2.7%
Terns Pharmaceuticals, Inc. (TERN)
Burroughs Amy L. — Director
Shares
2,341
Price
$38.07
Total Value
$89.11K
Shares Held After
301,218
% of Holdings
0.8%
MCKESSON CORP (MCK)
Smith LeAnn B — EVP & Chief HR Officer
Shares
190
Price
$945.00
Total Value
$179.55K
Shares Held After
2,989
% of Holdings
6.0%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
3,891
Price
$15.41
Total Value
$59.95K
Shares Held After
266,466
% of Holdings
1.4%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
3,065
Price
$15.46
Total Value
$47.38K
Shares Held After
270,357
% of Holdings
1.1%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
2,189
Price
$15.29
Total Value
$33.47K
Shares Held After
273,422
% of Holdings
0.8%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
11,104
Price
$15.36
Total Value
$170.55K
Shares Held After
275,611
% of Holdings
3.9%
SI-BONE, Inc. (SIBN)
Maheshwari Anshul — Chief Financial Officer
Shares
1,279
Price
$15.35
Total Value
$19.63K
Shares Held After
286,715
% of Holdings
0.4%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
2,033
Price
$15.30
Total Value
$31.09K
Shares Held After
544,369
% of Holdings
0.4%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
7,888
Price
$15.44
Total Value
$121.76K
Shares Held After
546,402
% of Holdings
1.4%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
2,236
Price
$15.29
Total Value
$34.20K
Shares Held After
554,290
% of Holdings
0.4%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
3,203
Price
$15.31
Total Value
$49.05K
Shares Held After
556,526
% of Holdings
0.6%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
39,764
Price
$15.29
Total Value
$608.07K
Shares Held After
559,729
% of Holdings
6.6%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
18,889
Price
$15.32
Total Value
$289.43K
Shares Held After
599,493
% of Holdings
3.1%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
3,893
Price
$15.29
Total Value
$59.51K
Shares Held After
618,382
% of Holdings
0.6%
SI-BONE, Inc. (SIBN)
FRANCIS LAURA — Director
Shares
15,569
Price
$15.35
Total Value
$239.01K
Shares Held After
622,275
% of Holdings
2.4%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops & Adm/Chief Legal Ofr
Shares
1,854
Price
$15.31
Total Value
$28.38K
Shares Held After
285,974
% of Holdings
0.6%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops & Adm/Chief Legal Ofr
Shares
11,569
Price
$15.34
Total Value
$177.43K
Shares Held After
287,828
% of Holdings
3.9%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops & Adm/Chief Legal Ofr
Shares
1,481
Price
$15.32
Total Value
$22.69K
Shares Held After
299,397
% of Holdings
0.5%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops & Adm/Chief Legal Ofr
Shares
3,296
Price
$15.41
Total Value
$50.81K
Shares Held After
300,878
% of Holdings
1.1%
SI-BONE, Inc. (SIBN)
PISETSKY MICHAEL A. — SVP, Ops & Adm/Chief Legal Ofr
Shares
2,556
Price
$15.39
Total Value
$39.34K
Shares Held After
304,174
% of Holdings
0.8%
Protagonist Therapeutics, Inc (PTGX)
Williams Lewis T — Director
Shares
18,000
Price
$82.42
Total Value
$1.48M
Shares Held After
7,825
% of Holdings
69.7%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
3,307
Price
$75.93
Total Value
$251.09K
Shares Held After
11,589
% of Holdings
22.2%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
4,793
Price
$75.57
Total Value
$362.22K
Shares Held After
14,896
% of Holdings
24.3%
BridgeBio Pharma, Inc. (BBIO)
Scott Randal W. — Director
Shares
1,900
Price
$74.34
Total Value
$141.25K
Shares Held After
19,689
% of Holdings
8.8%
GILEAD SCIENCES, INC. (GILD)
Dickinson Andrew D — Chief Financial Officer
Shares
3,000
Price
$154.43
Total Value
$463.29K
Shares Held After
167,779
% of Holdings
1.8%
Day One Biopharmaceuticals, Inc. (DAWN)
VASCONCELLES MICHAEL — Head of Research and Dev.
Shares
2,728
Price
$11.60
Total Value
$31.65K
Shares Held After
4,397
% of Holdings
38.3%
Day One Biopharmaceuticals, Inc. (DAWN)
Bender Jeremy — Director
Shares
15,459
Price
$11.60
Total Value
$179.34K
Shares Held After
204,603
% of Holdings
7.0%
Day One Biopharmaceuticals, Inc. (DAWN)
York Charles N II — COO and CFO
Shares
6,065
Price
$11.60
Total Value
$70.36K
Shares Held After
312,025
% of Holdings
1.9%
Day One Biopharmaceuticals, Inc. (DAWN)
Dubow Adam — Gen Counsel & Secretary
Shares
6,395
Price
$11.60
Total Value
$74.19K
Shares Held After
72,694
% of Holdings
8.1%
Day One Biopharmaceuticals, Inc. (DAWN)
Merendino Lauren — Chief Commercial Officer
Shares
5,814
Price
$11.60
Total Value
$67.45K
Shares Held After
60,157
% of Holdings
8.8%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
4,150
Price
$70.01
Total Value
$290.55K
Shares Held After
53,541
% of Holdings
7.2%
Arcellx, Inc. (ACLX)
Gilson Michelle — CHIEF FINANCIAL OFFICER
Shares
7,141
Price
$69.21
Total Value
$494.23K
Shares Held After
57,691
% of Holdings
11.0%
GILEAD SCIENCES, INC. (GILD)
Mercier Johanna — Chief Comm & Corp Aff Officer
Shares
200
Price
$155.62
Total Value
$31.12K
Shares Held After
120,288
% of Holdings
0.2%
GILEAD SCIENCES, INC. (GILD)
Mercier Johanna — Chief Comm & Corp Aff Officer
Shares
9,395
Price
$154.91
Total Value
$1.46M
Shares Held After
120,488
% of Holdings
7.2%
GILEAD SCIENCES, INC. (GILD)
Mercier Johanna — Chief Comm & Corp Aff Officer
Shares
18,405
Price
$154.18
Total Value
$2.84M
Shares Held After
129,883
% of Holdings
12.4%
LEXICON PHARMACEUTICALS, INC. (LXRX)
DEBBANE RAYMOND — Director
Shares
76,857
Price
$1.31
Total Value
$100.54K
Shares Held After
1,520,498
% of Holdings
5.1%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
7,875
Price
$480.75
Total Value
$3.79M
Shares Held After
0
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
BENKOWITZ MICHAEL — PRESIDENT AND COO
Shares
14,625
Price
$480.75
Total Value
$7.03M
Shares Held After
0
% of Holdings
100.0%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Hodgson Ian — Chief Operating Officer
Shares
847
Price
$7.38
Total Value
$6.25K
Shares Held After
51,080
% of Holdings
1.6%
OMNICELL, INC. (OMCL)
Manley Corey J — EVP&CHIEF LEGAL/ADMIN OFFICER
Shares
4,243
Price
$36.59
Total Value
$155.25K
Shares Held After
85,496
% of Holdings
4.7%
EyePoint, Inc. (EYPT)
Ribeiro Ramiro — Chief Medical Officer
Shares
2,437
Price
$15.00
Total Value
$36.55K
Shares Held After
0
% of Holdings
100.0%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Adam S — Director
Shares
6,000
Price
$16.08
Total Value
$96.48K
Shares Held After
2,284,379
% of Holdings
0.3%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Adam S — Director
Shares
15,000
Price
$16.08
Total Value
$241.20K
Shares Held After
2,290,379
% of Holdings
0.7%
Gemini Therapeutics, Inc. (GMTX)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
3,231
Price
$62.86
Total Value
$203.10K
Shares Held After
54,324
% of Holdings
5.6%
Gemini Therapeutics, Inc. (GMTX)
Quisel John D — Director
Shares
13,264
Price
$62.86
Total Value
$833.78K
Shares Held After
226,064
% of Holdings
5.5%
Gemini Therapeutics, Inc. (GMTX)
Savage William Jacob — Chief Medical Officer
Shares
3,256
Price
$62.86
Total Value
$204.67K
Shares Held After
92,589
% of Holdings
3.4%
Gemini Therapeutics, Inc. (GMTX)
Khara Rahul — Chief Legal Officer
Shares
2,853
Price
$62.86
Total Value
$179.34K
Shares Held After
52,173
% of Holdings
5.2%
Gemini Therapeutics, Inc. (GMTX)
Stephenson Pamela — Chief Commercial Officer
Shares
5,531
Price
$62.86
Total Value
$347.68K
Shares Held After
80,998
% of Holdings
6.4%
PULSE BIOSCIENCES, INC. (PLSE)
Danahy Kevin Patrick — Chief Commercial Officer
Shares
20,000
Price
$23.63
Total Value
$472.60K
Shares Held After
43,298
% of Holdings
31.6%
Showing 2901–2950 of 5535 transactions (page 59 of 111)